PubMedCrossRef 50. Puca R, Nardinocchi L, D’Orazi G: Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2. J Exp Clin Cancer Res 2008, 27:1–7.CrossRef 51. Li XL, Arai Y, Harada H, Shima Y, Yoshida H, Rokudai S, Aikawa Y, Kimura A, Kitabayashi I: Mutations of the HIPK2 gene in acute myeloid leukemia and myelodisplatic sindrome impair AML-1 and p53-mediated transcription. Oncogene 2007, 26:7231–7239.PubMedCrossRef 52. Calzado MA, de la Vega L, Moller A, Bowtell DD, Schmitz ML: An inducible this website autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol 2009,

11:85–91.PubMedCrossRef 53. Semenza GL: Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29:625–634.PubMedCrossRef 54. Nardinocchi L, Puca R, Guidolin D, Belloni AS, Bossi G, Michiels C, Sacchi A, Onisto M, D’Orazi G: Transcriptional regulation of hypoxia-inducible factor 1α by HIPK2 suggests

a novel mechanism to restrain tumor growth. Biochem Biophys. Acta MCR 2009, 1793:368–377.CrossRef 55. Nardinocchi L, Puca R, Sacchi A, D’Orazi G: Inhibition LY2874455 manufacturer of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis. Mol Cancer 2009, 8:1.PubMedCrossRef 56. Puca R, Nardinocchi L, Pistritto G, D’Orazi G: Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol 2008, 109:403–410.PubMedCrossRef 57. Sendoel A, Kohler I, Fellmann C, Lowe SW, Hengsrtner MO: HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase. Nature 2010, 465:577–583.PubMedCrossRef 58. Nardinocchi L, Puca R, D’Orazi G: HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation. Aging (Albany NY) 2011, 3:33–43. 59. Nardinocchi Aurora Kinase L, Pantisano V, Puca R, Porru M, Aiello A, Grasselli A, Leonetti C, Safran M, Rechavi G, Givol D, Farsetti A, D’Orazi G: Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo. PLoS One 2010, 5:1–12.CrossRef 60. Sheffer M, Simon AJ, Jacob-Hirsch J, Rechavi G, Domany E, Givol D, D’Orazi G: Genome-wide analysis

discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation. Oncotarget 2011, 2:1191–1202.PubMed 61. Rinaldo C, Moncada A, Gradi A, Ciuffini L, D’Eliseo D, Siepi F, Prodosmo A, Giorgi A, Pierantoni GM, Trapasso F, Guarguaglini G, Bartolazzi A, Cundari E, Schininà ME, Fusco A, Soddu S: HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody. Mol Cell 2012, 47:87–98.PubMed 62. Ganem NJ, Storchova Z, Pellman D: Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007, 17:157–162.PubMedCrossRef 63. Nardinocchi L, Puca R, Sacchi A, D’Orazi G: HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA. Biochem selleck chemical Biophys Res Commun 2007, 361:249–255.

Chem Rev 1995,95(1):69–96.CrossRef 55. Wang X, Zhi L, Mullen K: Transparent, conductive graphene electrodes for dye-sensitized solar cells. Nano Lett 2007,8(1):323–327.CrossRef 56. Zhao D, Sheng G, Chen C, Wang X: Enhanced photocatalytic degradation of methylene blue under visible irradiation on graphene@TiO 2 dyade structure. Appl Catal, B 2012, 111–112:303–308. 57. Li Y, Wang W-N, Zhan Z, Woo M-H, Wu C-Y, Biswas P: Photocatalytic reduction of CO 2 with H 2 O on mesoporous silica BIX 1294 research buy supported Cu/TiO 2 catalysts. Appl Catal, B 2010,100(1–2):386–392. 58. Zhang N, Ouyang S, Kako T, Ye J: Mesoporous zinc germanium oxynitride for CO 2 photoreduction under visible light. Chem Commun 2012,48(9):1269–1271.CrossRef

Competing interests The authors declare that they have no competing interests. Authors’ contributions LLT and WJO conceived and designed the experimental Selleckchem LDN-193189 strategy. LLT performed the experiments and prepared the

manuscript. SPC and ARM supervised the whole work and revised the manuscript. All authors read and approved the final manuscript.”
“Background For the advantages of low cost, environmental friendliness, easy fabrication, and light-to-energy conversion with relatively high efficiency, dye-sensitized solar cells (DSSCs) are listed PF477736 as one of the most promising photovoltaic devices [1–6]. A typical DSSC has a sandwich structure: a dye-sensitized semiconductor photoanode, an electrolyte with a redox couple (triiodide/iodide), and a counter electrode (CE) catalyzing the reduction of I3 – to I-. The CE in photoelectrochemical solar cells plays an important role in transferring electrons from the 3-mercaptopyruvate sulfurtransferase external

circuit back to the redox electrolyte for catalytic reduction of the redox electrolyte. Up to now, the most conventional CE is fluorine-doped tin oxide (FTO) glass coated with a thin layer of platinum, which has the excellent electrocatalytic activity for the reduction of charge carriers in an electrolyte as well as high conductivity. However, Pt is scarce and expensive which makes the cost of DSSCs high and limits the potential large-scale applications. To address this issue, efforts have been made to replace the Pt CE. Currently, the researches about a CE alternative were focused on two aspects. Firstly, different materials were tried to be used as CE in DSSC devices, such as carbon-based materials [7–9], conductive polymer [10, 11], and inorganic semiconductor materials [12–14]. Second, for the certain given CE materials, the effect of morphology on the efficiency of DSSC devices has received much attention. For example, in carbon-based CE materials, the different morphologies, such as nanotubes [15] and mesoporous [16] and hierarchical [17] structures, were used as CE in DSSC devices. However, for a special CE material, the influence of different phases on the efficiency of DSSC has not been reported.

The statistical significance between means of the different prostate group’s samples was assessed by the Fisher exact test and the one-way ANOVA test at p≤0.05 (GraphPad PRISMA 5.0 computer program). Results We examined human histological specimens (NP, BPH and PC) by immunohistochemistry to evaluate the relationship between the co-expression of prostate- associated antigens (PSMA and PSA) and the degree of vascularization (intensity of immunoreaction to CD34). We didn’t see any immunoreactivity in the negative controls incubated with blocking peptides

(Figure 1A). Immunorectivity for PSMA appeared in 83% of NP, 86% of BPH and 97% of PC samples. In NP and BPH samples, PSMA was exclusively expressed in the cytoplasm of luminal epithelial cells, whereas we found it only expressed in the tumor cells of the PC specimens. We wanted to look at the expression of PSMA

Selleck JNK-IN-8 in blood vascular, we stained adjacent sections with anti-CD34 and anti-PSMA antibodies AC220 order of our samples and we found that endothelium of both benign and malignant prostate tissues were deprived from PSMA expression (Figure 1C, G and 1K). Figure 1 H & E stained slides in NP (B), BPH (F) and PC (J); immunohistochemical localizations of PSMA, PSA and CD34. Negative control (A). NP showing weak cytoplasmic staining for PSMA (C) and PSA (D) in epithelial cells. CD34 was found at low level in membranous and cytoplasmic endothelial cells in NP (E) and BPH (I). BPH showing weak membranous staining for PSMA (G) and strong membranous and cytoplasmic staining for PSA (H) in prostatic epithelial cells. PSMA (K) and CD34 (M) showed strong immunoreactions in infiltrating prostatic carcinoma. PSA (L) showed weak cytoplasmic immunoreactions of epithelial cells in PC. Scale bars: A-G, I-M, 20 μm; H, 30 μm. We used Motic advanced software to calculate the optic density (OD) that correlates with the antigen expression. We found that the mean of PSMA expression was significantly BIX 1294 increased in benign prostate glands compared with normal prostate tissue (respectively Resveratrol 16.14 ± 0.17 and 3.7 ± 0.18) (p = 0.008). The highest level of PSMA expression

was found in primary prostate cancer (30.72 ± 0.85) which significantly differed from benign (p < 0.0001) and normal prostatic tissue (p < 0.0001) (Figure 2A). Unlike PSMA, PSA expression was found the highest in hyperplastic epithelial cells (Figure 2B). Scanty immunoreactivity to PSA was localized in the cytoplasm of epithelial cells in normal prostate (Figure 1D). Figure 2B showed that the intensity of immunoreaction to PSA decreased from BPH samples to prostate adenocarcinoma (34.39 ± 0.53 and 17.85 ± 1.21, respectively) (p < 0.0001). As shown in this figure, 57% of PC samples positive for PSA have a similar PSA expression level distribution to NP samples, whereas 43% have a similar PSA expression level distribution to BPH samples. PSA staining was present in 83% of NP, 75% of BPH samples and 74% of PC samples.

SigE contributes to cytotoxicity to macrophages We further tested whether RB50ΔsigE interacts differently than RB50 with another major bactericidal component in the bloodstream, phagocytes. B. bronchiseptica is cytotoxic to macrophages, and this toxicity has been attributed to the activities of the type three secretion system (TTSS) [49]. To test

the role of SigE in macrophage cytotoxicity, RAW264.7 murine macrophages were incubated for 4 hours at an MOI of 10 with RB50, RB50 lacking sigE, or RB50 lacking a functional TTSS (WD3). In this experiment, both the RB50 and RB50ΔsigE strains contained the empty cloning selleckchem vector pEV to allow direct comparisons with the complemented strain, RB50ΔsigE pSigE. Cytotoxicity was determined by measuring LDH release from the treated macrophages. WD3 caused little cytotoxicity, similar to treatment with medium alone. RB50ΔsigE pEV caused approximately 50% less cytotoxicity than wild-type RB50 pEV (Figure 5). This defect in cytotoxicity was complemented by supplying the sigE gene on the plasmid pSigE (Figure 5), indicating that

loss of sigE negatively impacts the ability of RB50 to kill macrophages. Figure 5 RB50Δ sigE is less cytotoxic to macrophages than RB50. RAW 264.7 cells were incubated at an MOI of 10 with medium containing RB50 pEV, RB50ΔsigE pEV, RB50ΔsigE pSigE, TTSS-deficient RB50 MK5108 ic50 strain WD3, or medium alone for 4 hours in the presence of 1 mM IPTG to induce expression of sigE from the pLac promoter of pSigE. The average percent cytotoxicity of four wells in four separate experiments as measured by (LDH release from a well/LDH release from the positive control well) x100 ± SE is shown. The differences in percent cytotoxicity between RB50ΔsigE pEV and either RB50 pEV or RB50ΔsigE pSigE are statistically significant Epothilone B (EPO906, Patupilone) (** indicates P value < 0.01), while the cytotoxicities of RB50 pEV and RB50ΔsigE pSigE are not significantly

different. RB50ΔsigE is more efficiently phagocytosed and killed by PMNs To test if RB50ΔsigE is more susceptible to another bactericidal mechanism, phagocytosis by peripheral blood polymorphonuclear leukocytes (PMNs), RB50 and RB50ΔsigE were incubated with freshly isolated human PMNs and attachment to, phagocytosis by, and killing by these cells were measured. PMNs bound RB50ΔsigE more efficiently than RB50 (Figure 6A), and significantly more RB50ΔsigE than RB50 were phagocytosed by PMNs (Figure 6B). However, the number of viable BV-6 concentration intracellular RB50ΔsigE was ~50% of the numbers of viable RB50 (Figure 6C, left panel). When differences in attachment and phagocytosis were taken into consideration, significantly more internalized RB50ΔsigE were killed compared to RB50 (Figure 6C, right panel). Together, these data indicate that SigE contributes to B. bronchiseptica resistance to phagocytosis and killing by PMNs.

The resulting cloned elementary bodies (EBs) were grown to high titers and were partially purified by centrifugation of lysates of infected cells through a 30% MD-Gastroview® pad (Mallinckrodt Inc. St Louis). Generation of recombinant

clones for complete genome sequence analysis Recombinants isolated for genome analysis were generated from two sets of crosses (Table 1). The first of these involved two parental strains; R788 cost L2-434ofl and F(s)/70rif and the second was a three-way cross with the parental strains F(s)/70tet-rif, J/6276rif and L2-434ofl. Recombination experiments were conducted as previously described [5]. Briefly, crosses were performed in McCoy cells seeded in sets of individual shell vials. The monolayers DNA Damage inhibitor were then infected with

different combinations of drug-resistant strains each at an MOI = 2, ensuring infections of cells with both strains. Cultures were incubated for 48 h post-infection in the absence of antibiotics and were then detached and lysed using a -80C/37C AR-13324 datasheet freeze-thaw cycle [5]. Potential recombinants were selected by inoculating 50 μl of the freeze-thaw lysates from each shell vial onto a new shell vial monolayer and overlaying with a medium containing antibiotics at 1/4 the MIC for each resistant parental strain. In the case of the three-way cross [F(s), J, L2], three different combinations of drug were applied to the infected monolayers (MOI = 2). These combinations included ofloxacin/rifampicin, Cell press ofloxacin/tetracycline, and ofloxacin/rifampicin/tetracycline. Generation of recombinant chlamydial strains for analysis of recombination hot spots Multiple independent shell vials containing confluent McCoy cells were inoculated sequentially

with ofloxacin-resistant D/UW3Cx and rifampin-resistant L1/440/LN or L3/404/LN strains, and incubated 48 h in medium lacking antibiotics. Monolayers were lysed and used as inocula onto fresh McCoy cells at MOI = 1, and incubated in the presence of 4X the MIC of the drugs used for selection, rifampin and ofloxacin. These concentrations were previously determined to be sufficient to select for individual recombinant strains resistant to both drugs. Incubation of either parent in this combination and concentration of antibiotics at MOI = 1 never yielded a doubly resistant mutant parent. Chlamydial recombinants growing in this mixture of antibiotics were propagated and cloned by limiting dilution. Only a single recombinant progeny was collected from each lineage from a single original inoculated shell vial. DNA was harvested from these clones, and PCR primers were created that flanked regions of suspected recombination hotspots identified by Srinivasan and colleagues [24]. The Phusion high fidelity DNA polymerase (New England Biolabs, Ipswich, MA) was used to generate PCR products from these regions, and these were sequenced at the Oregon State University Center for Genomics Research and Biocomputing.

Optimization of CS and TPP concentrations To optimize the CS/TPP ratio based on particle size and the entrapment efficiency, various CS concentrations (0.2%, 0.3%, and 0.4% (w/v)) were prepared from the stock solution. The concentrated TPP solution (0.5% (w/v)) was used in order not to dilute the CS/ASNase II mixture

more than necessary. From this stock solution, different volumes of TPP solution (Table 1) were added dropwise (10 μl per 10 s interval) to 1 ml of each CS concentration (containing 1 mg lyophilized ASNase II) with stirring (about 800 rpm), with particular care taken to avoid foam formation. In addition to the applied volumes of TPP, Table 1 shows the final concentrations of the added TPP (% w/v). All procedures were carried out at room EPZ5676 molecular weight temperature (25°C). After 10 min of stirring, the particles were collected by centrifugation at 25,000 × g, 25°C for 30 min in 50-μl find more glycerol bed. The supernatants selleck chemicals were separated to estimate the entrapment efficiency (%). The pellets of the particles in glycerol were suspended in 1 ml of distilled water to determine the average sizes (nm). Table 1 Chitosan concentrations,

TPP volumes from TPP stock solution (0.5%  w / v ), and final TPP concentrations in final prepared nanoparticle suspensions CS (% w/ v) TPP (ml) TPP (% w/ v) 0.2 0.1 0.04 0.12 0.05 0.14 0.06 0.3 0.15 0.06 0.18 0.07 0.21 0.08 0.4 0.2 0.08 0.24 0.095 0.28 0.11 Optimization of protein loading The stable and suitable CS/TPP ratio from the previous step was selected in order to investigate the optimal entrapment efficiency and loading capacity of CSNPs, loaded with five different Janus kinase (JAK) amounts of protein

(1, 2, 3, 4, and 5 mg). Nanoparticles were prepared according to the procedure given above by adding a certain amount of lyophilized ASNase II in 1 ml of optimal CS solution. After centrifugation, the supernatants were separated to estimate the entrapment efficiency. The pellets of the particles in glycerol were suspended in 1 ml of DDW and dispersed by sonication. The size (nm), zeta potential (mV), protein content (mg), entrapment efficiency (%), and loading capacity (%) of the particles were determined. Entrapment efficiency estimation In order to determine the entrapment efficiency of the nanoparticles, it was necessary to detect by the Lowry method [21] the amount of free enzyme in the clear supernatant.

No. IN-203407-3, UNAM, Mexico. A. E. González-González thanks the Biological Science Graduate Program of UNAM and the scholarship of CONACYT (Ref. No. 23492). References 1. Anderson H, Honish L, Taylor G, Johnson M, Tovstiuk C, Fanning A, Tyrrell G, Rennie R, Jaipaul J, Sand C, Probert S: Histoplasmosis cluster, golf course, Canada. Emerg Infect Dis 2006, 12:163–165.PubMedCrossRef check details 2. Calanni LM, Pérez R, Brasili S,

Schmidt NG, Iovannitti CA, Zuiani MF, Negroni R, Finquelievich J, Canteros CE: Brote de histoplasmosis en la Provincia de Neuquén, Patagonia Argentina. Rev Iberoam Micol 2013. doi:10.1016/j.riam.2012.12.007 3. Guimarães AJ, de Cerqueira MD, Nosanchuk JD: Surface architecture of Histoplasma capsulatum . Front Microbiol 2011, 2:225. doi: 10.3389/fmicb.2011.00225PubMedCentralPubMedCrossRef selleck kinase inhibitor 4. Taylor ML, Reyes-Montes

MR, Chávez-Tapia CB, Curiel-Quesada E, Duarte-Escalante E, Rodríguez-Arellanes G, Peña-Sandoval GR, Valenzuela-Tovar F: Ecology and molecular epidemiology findings of Histoplasma capsulatum , in Mexico. In Research Advances in Microbiology. Edited by: Benedik M. Kerala: Global Research Network; 2000:29–35. 5. Chávez-Tapia CB, Vargas-Yáñez R, Rodríguez-Arellanes G, Peña-Sandoval GR, Flores-Estrada JJ, LGK-974 cell line Reyes-Montes MR, Taylor ML: I. El murciélago como reservorio y responsable de la dispersión de Histoplasma capsulatum en la naturaleza. II. Papel de los marcadores moleculares del hongo aislado de murciélagos infectados. Rev Inst Nal Enf Resp Mex 1998, 11:187–191.

6. González-González AE, Aliouat-Denis CM, Carreto-Binaghi LE, Ramírez JA, Rodríguez-Arellanes G, Demanche C, Chabé M, Aliouat EM, Dei-Cas E, Taylor ML: An Hcp100 gene fragment reveals Histoplasma capsulatum presence in lungs of Tadarida brasiliensis migratory bats. Epidemiol Infect 2012, 140:1955–1963.PubMedCrossRef 7. Taylor ML, Chávez-Tapia CB, Vargas-Yáñez R, Rodríguez-Arellanes G, Peña-Sandoval GR, Toriello C, Pérez A, Reyes-Montes MR: Environmental conditions favoring bat infections with Histoplasma capsulatum in Mexican shelters. Am J Trop Med Hyg 1999, 61:914–919.PubMed 8. Taylor ML, Hernández-García L, Estrada-Bárcenas D, Salas-Lizana R, Zancopé-Oliveira RM, García De La Cruz S, Galvao-Dias MA, Curiel-Quesada E, Canteros CE, Bojórquez-Torres G, Adenosine Bogard-Fuentes CA, Zamora-Tehozol E: Genetic diversity of Histoplasma capsulatum isolated from infected bats randomly captured in Mexico, Brazil, and Argentina, using the polymorphism of (GA)n microsatellite and its flanking regions. Fungal Biol 2012, 116:308–317.PubMedCrossRef 9. Kasuga T, White TJ, Koenig G, McEwen J, Restrepo A, Castañeda E, Da Silva-Lacaz C, Heins-Vaccari EM, De Freitas RS, Zancopé-Oliveira RM, Zhenyu Q, Negroni R, Carter DA, Mikami Y, Tamura M, Taylor ML, Miller GF, Poonwan N, Taylor JW: Phylogeography of the fungal pathogen Histoplasma capsulatum .

It is worth mentioning that the Anderson localization effect, an important signature of strong localization which may be affected by a magnetic field applied perpendicular to the graphene plane, was observed in a double-layer graphene heterostructure [38], but not in single-layer pristine graphene. Moreover, the disorder of single graphene is

normally lower than those of multi-layer graphene devices. Since one needs sufficient disorder in order to see the Torin 1 cell line I-QH transition [11], multi-layer graphene seems to be a suitable choice for studying such a transition in a pristine graphene-based system. Besides, the top and bottom layers may isolate the MAPK inhibitor environmental impurities [39–42], making multi-layer graphene a stable and suitable system for observing the I-QH transition. In this paper, we report magnetotransport measurements on a multi-layer graphene flake. We observe an approximately temperature-independent point in the measured longitudinal resistivity ρ xx which can be ascribed to experimental evidence for the direct I-QH transition. At the crossing field B c in which ρ xx is approximately T-independent, ρ xx is close to ρ xy . In contrast, the product of the quantum mobility determined from the oscillations in ρ xx

and B c is ≈ 0.37 which is considerably smaller than 1. Thus, our experimental results suggest that different mobilities need to be introduced when considering the direct I-QH transition in graphene-based VS-4718 chemical structure devices. Methods A multi-layer graphene flake, mechanically exfoliated from natural graphite, was deposited onto a 300-nm-thick SiO2/Si substrate. Optical microscopy was used to locate the ID-8 graphene flakes, and the thickness of multi-layer graphene is 3.5 nm, checked by atomic force microscopy. Therefore, the layer number of our graphene device is around ten according to the 3.4 Å graphene inter-layer distance [1, 43]. Ti/Au contacts were deposited

on the multi-layer graphene flake by electron-beam lithography and lift-off process. The multi-layer graphene flake was made into a Hall bar pattern with a length-to-width ratio of 2.5 by oxygen plasma etching process [44]. Similar to the work done using disordered graphene, our graphene flakes did not undergo a post-exfoliation annealing treatment [45, 46]. The magnetoresistivity of the graphene device was measured using standard AC lock-in technique at 19 Hz with a constant current I = 20 nA in a He3 cryostat equipped with a superconducting magnet. Results and discussion Figure 1 shows the curves of longitudinal and Hall resistivity ρ xx (B) and ρ xy (B) at T = 0.28 K.

0.1 [47]. The robustness of the ML topologies was evaluated using a recently developed Shimodaira-Hasegawa-like test for branches implemented in PhyML v3.0.1 [47]. For the sake of clarity, a small selection of the most relevant sequences was performed to show herein, based on the results Selleckchem HDAC inhibitor of the phylogenetic analysis with the full set of homologous sequences. Sequencing of plasmid pSfr64a Plasmid pSfr64a was purified by the Hirsch method [48], and

used to construct a shotgun library with inserts of approximately 1-2 kb. A total of 1970 high-quality readings were collected by using the ABI3730XL automatic DNA sequencing machine (Applied Biosystems, Foster City, CA). Gaps were filled in by performing appropriate PCR amplification.

Assemblages were obtained by the PhredPhrap-Consed software [49–51]. The quality of the final assembly was less than 1 error per 100,000 bases and had an average coverage of 6.5X. Annotation Open reading frames were predicted by using GLIMMER 3.0 [52, 53] and annotation was carried out with the help of BLASTX [54] comparisons against the GenBank nonredundant database [55], INTERPRO [56] searches, and manual curation by using ARTEMIS [57]. To compare partial genomic sequences with the nonredundant database of GenBank, BLASTX searches were performed, and the top hits were classified with respect to organisms with which they matched. Nucleotide sequence accesion number Akt activity Plasmid pSfr64a accession number is GenBank: CP002245. GR64 nifH, recA, and rpoB accesion numbers are respectively GenBank: JN034672, JN034673, JN034674. Acknowledgements We are grateful to José Luis Fernández, Javier Rivera and Nadya Chaira for excellent technical assistance, and to Paul Gaytán and Eugenio López those for synthesis of oligonucleotides. This work was partially supported by grant IN203109 from DGAPA, UNAM. Electronic supplementary material Additional file 1: Similarity of pSfr64a ORFs to genes located in the chromosome of NGR234, pRet42a and pRet42d plasmids. Lists all the

ORFs of pSfr64a, their predicted function, e-value and % of identity to the corresponding ORFs with highest similarity, located on the chromosome of S. fredii NGR234, and R. etli Salubrinal mw plasmids pRet42a and pRet42d. (PDF 146 KB) References 1. Masson-Boivin C, Giraud E, Perret X, Batut J: Establishing nitrogen-fixing symbiosis with legumes: how many rhizobium recipes? Trends in Microbiol 2009, 17:458–466.CrossRef 2. Romero D, Brom S: The symbiotic plasmids of the Rhizobiaceae . In Plasmid biology. Edited by: Phillips G, Funell B. Washington DC, ASM Press; 2004:271–290. 3. Ding H, Hynes MF: Plasmid transfer systems in the rhizobia. Can J Microbiol 2009, 55:917–927.PubMedCrossRef 4. Danino VE, Wilkinson A, Edwards A, Downie JA: Recipient induced transfer of the symbiotic plasmid pRL1JI in Rhizobium leguminosarum bv. viciae is regulated by a quorum-sensing relay. Mol Microbiol 2003, 50:511–525.

For each habitat we calculated the ratio of the average difference in population distributions of

habitats inoculated from the same cultures ( same >) relative to the average difference to all habitats inoculated from different cultures ( different >): d relative = same >/ different >. The red arrows indicate , obtained by averaging log[d relative ] over all habitats of a given device type. The blue distribution shows the values of relative > obtained find more using 10.000 randomizations, where each population distribution was assigned to a randomly chosen habitat. Note that values of d relative were log transformed before averaging, the figure shows the back-transformed values. (A) Devices of type-1. (B) Devices of type 2. Note how in all cases the relative > for the real dataset (in red) is much lower than the relative > obtained from the randomized dataset (in blue). *** indicates p < 0.001. (C) Comparison of the degree of similarity observed in type-1 and 2 devices combined to that observed in devices of type-5. For both groups the differences between population distributions in habitats inoculated from the same culture set (d same ) and the Foretinib concentration difference between population distributions in habitats inoculated from different culture sets (d different ) is shown. Values of d same and d different obtained for habitats inoculated from the same culture sets were averaged together. N.S. indicates p > 0.05 in a Wilcoxon rank sum test

(comparison of d different between type 1 and 5 devices) or Wilcoxon signed rank test (comparison between d same and d different for type 5 devices). (PDF 123 KB) Additional Fludarabine concentration file 10: Device type-4 where the two habitats where inoculated in reverse orientation. (A) Kymograph of fluorescence Selleck BIBW2992 intensity for a device of type-4, where only the two outer most habitats

are used. The orientation of inoculation was reversed for the two habitats, i.e. the red strain was inoculated from the right into habitat 1 and from left into habitat 2, see panel B. Note that the kymograph of habitat 2 is horizontally mirrored to reveal the similarity with habitat 1. (B) Schematic of the inoculation locations. (PDF 4 MB) Additional file 11: Experimental Protocol. Protocol for the experiments using type-1 (top part), type-2 (middle part) and type-5 (lower apart) devices. Devices 10 and 11 (type-2) were imaged in parallel on the same microscope setup, after being inoculate from the same set of initial cultures. For devices of types 1 and 2 overnight cultures were started by taking a sample (of undefined volume) from a single −80°C stock for each strain, for devices of type-5 these same −80°C stocks (one for each strain) were split into aliquots and each overnight culture was started using a defined volume of a thawed aliquot. The following morning cultures were back-diluted 1:1000 to result in the initial culture with which the devices were inoculated. (PDF 384 KB) Additional file 12: Overview of all devices of type-5.